Wednesday , October 18 2017
Home / Letter From The Editor / Editor’s Note: Inflammation Markers, Treatment Regimens and Patient Confusion

Editor’s Note: Inflammation Markers, Treatment Regimens and Patient Confusion

Last week our publisher, Steve Freed, shared some great Homerun Slides on how Type 2 diabetes develops and what role hormones play in the progression of the disease. Your response was overwhelming and this week Steve brings us the second installment with some more great slides on inflammation markers. In this week’s Clinical Gems, Dr. Edelman helps us access how we are doing with our treatment regimens and our weekly diabetes Disaster Averted examines how patients often get confused by the simplest things.